Search Results - Dewi Vernerey
- Showing 1 - 15 results of 15
-
1
-
2
A comparison of target volumes drawn on arterial and venous phase scans during radiation therapy planning for patients with pancreatic cancer: the PANCRINJ study by Fabien Zaidi, Paul Calame, Cédric Chevalier, Julie Henriques, Dewi Vernerey, Lucine Vuitton, Bruno Heyd, Christophe Borg, Jihane Boustani
Published in Radiation Oncology (2024-07-01)Get full text
Article -
3
Muscle Loss During First‐Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity by Pauline Parent, Frédéric Pigneur, Marc Hilmi, Aurélien Carnot, Marie‐Line Garcia Larnicol, Dewi Vernerey, Alain Luciani, Pascal Hammel, Julie Henriques, Cindy Neuzillet, Anthony Turpin
Published in Journal of Cachexia, Sarcopenia and Muscle (2025-02-01)Get full text
Article -
4
Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies by Julien Magne, Alizée Jenvrin, Adrien Chauchet, Olivier Casasnovas, Anne Donzel, Laurence Jego, Bernard Aral, Julien Guy, Nathalie Nadal, Dewi Vernerey, Patrick Callier, Francine Garnache-Ottou, Christophe Ferrand
Published in Experimental Hematology & Oncology (2018-02-01)Get full text
Article -
5
Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis... by Christelle de La Fouchardière, Jaafar Bennouna, David Tougeron, Thierry André, Christophe Tournigand, Christophe Borg, Romain Cohen, Thibault Mazard, Dewi Vernerey, Frédéric Pigneur, Julie Henriques, Aurélia Meurisse, Benoist Chibaudel, Leonard Depotte, Paula Nay
Published in Journal for ImmunoTherapy of Cancer (2025-05-01)Get full text
Article -
6
RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer:... by Christelle de La Fouchardière, Jaafar Bennouna, David Tougeron, Magali Svrcek, Thierry André, Christophe Tournigand, Christophe Borg, Romain Cohen, Marie-Line Garcia-Larnicol, Thibault Mazard, Yves Menu, Dewi Vernerey, Aurélia Meurisse, Benoist Chibaudel
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article -
7
SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors by Pascal Hammel, Denis Smith, Pauline Afchain, Sophie Dominguez-Tinajero, Jean-François Seitz, Astrid Lievre, Eric Van Cutsem, Eric Assenat, Frédéric Di Fiore, Marc Peeters, Iradj Sobhani, Eric Raymond, Emilie Charton, Dewi Vernerey, Louis De Mestier, Catherine Lombard-Bohas
Published in Therapeutic Advances in Medical Oncology (2024-11-01)Get full text
Article -
8
Deciphering human endogenous retrovirus expression in colorectal cancers: exploratory analysis regarding prognostic value in liver metastasesResearch in context by Julien Viot, Romain Loyon, Nawfel Adib, Pierre Laurent-Puig, Aurélien de Reyniès, Fabrice André, Franck Monnien, Thierry André, Magali Svrcek, Anthony Turpin, Zohair Selmani, Laurent Arnould, Laura Guyard, Nicolas Gilbert, Anthony Boureux, Olivier Adotevi, Angélique Vienot, Syrine Abdeljaoued, Dewi Vernerey, Christophe Borg, Daniel Gautheret
Published in EBioMedicine (2025-06-01)Get full text
Article -
9
First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort by Nicolas Adamus, Julien Edeline, Julie Henriques, Nadim Fares, Thierry Lecomte, Anthony Turpin, Dewi Vernerey, Mathilde Vincens, Brice Chanez, David Tougeron, Christophe Tournigand, Eric Assenat, Matthieu Delaye, Sylvain Manfredi, Olivier Bouché, Nicolas Williet, Angelique Vienot, Lorraine Blaise, Léo Mas, Cindy Neuzillet, Alice Boilève, Gaël S. Roth
Published in JHEP Reports (2025-02-01)Get full text
Article -
10
Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab by Quentin Jacquinot, Quentin Jacquinot, Nathalie Meneveau, Antoine Falcoz, Malika Bouhaddi, Malika Bouhaddi, Pauline Roux, Bruno Degano, Marion Chatot, Elsa Curtit, Elsa Curtit, Laura Mansi, Laura Mansi, Marie-Justine Paillard, Fernando Bazan, Loïc Chaigneau, Erion Dobi, Guillaume Meynard, Dewi Vernerey, Xavier Pivot, Fabienne Mougin, Fabienne Mougin
Published in Frontiers in Cardiovascular Medicine (2022-09-01)Get full text
Article -
11
Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial by Laura Mansi, Olivier Adotevi, Marie Kroemer, Laurie Spehner, Adeline Bouard, Marine Jary, Romain Loyon, Christophe Borg, Dewi Vernerey, Syrine Abdeljaoued, Myriam Ben Khelil, Quentin Lepiller, Emeline Orillard, Antoine Falcoz, Hamadi Almotlak, Stefano Kim, Elsa Curtit, Guillaume Meynard, Charlee Nardin, Kamal Asgarov, Ugo Chartral, Virginie Mougey, Morgane Lopez
Published in BMJ Oncology (2023-12-01)Get full text
Article -
12
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study by Stefano Kim, Véronique Vendrely, Angélique Saint, Thierry André, Pauline Vaflard, Emmanuelle Samalin, Simon Pernot, Oliver Bouché, Mustapha Zubir, Jérôme Desrame, Christelle de la Fouchardière, Denis Smith, François Ghiringhelli, Angélique Vienot, Marion Jacquin, Elodie Klajer, Thierry Nguyen, Éric François, Julien Taieb, Karine Le Malicot, Dewi Vernerey, Aurélia Meurisse, Christophe Borg
Published in Experimental Hematology & Oncology (2023-07-01)Get full text
Article -
13
Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal... by Stefano Kim, Stefano Kim, Stefano Kim, Jihane Boustani, Dewi Vernerey, Véronique Vendrely, Ludovic Evesque, Eric Francois, Laurent Quero, Laurent Quero, Francois Ghiringhelli, Christelle de la Fouchardière, Laëtitia Dahan, Oliver Bouché, Benoist Chibaudel, Farid El Hajbi, Chloé Vernet, Magali Rebucci-Peixoto, Alexandra Feuersinger, Christophe Maritaz, Christophe Borg, Christophe Borg, Christophe Borg
Published in Frontiers in Oncology (2022-08-01)Get full text
Article -
14
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomi... by Angélique Vienot, Marion Jacquin, Magali Rebucci-Peixoto, Dimitri Pureur, François Ghiringhelli, Eric Assenat, Pascal Hammel, Olivier Rosmorduc, Morgane Stouvenot, Manon Allaire, Mohamed Bouattour, Hélène Regnault, Serge Fratte, Eric Raymond, Emilie Soularue, Stéphanie Husson-Wetzel, Vincent Di Martino, Allison Muller, Anne-Laure Clairet, Christine Fagnoni-Legat, Olivier Adotevi, Aurélia Meurisse, Dewi Vernerey, Christophe Borg
Published in BMC Cancer (2023-07-01)Get full text
Article -
15
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma by Stefano Kim, Aurélia Meurisse, Laurie Spehner, Morgane Stouvenot, Eric François, Bruno Buecher, Thierry André, Emmanuelle Samalin, Marine Jary, Thierry Nguyen, Farid El Hajbi, Nabil Baba-Hamed, Simon Pernot, Marie-Christine Kaminsky, Olivier Bouché, Jerome Desrame, Mustapha Zoubir, François Ghiringhelli, Aurélie Parzy, Christelle de la Fouchardiere, Fatiha Boulbair, Zaher Lakkis, Elodie Klajer, Marion Jacquin, Julien Taieb, Véronique Vendrely, Dewi Vernerey, Christophe Borg
Published in Therapeutic Advances in Medical Oncology (2020-12-01)Get full text
Article
